[Other forms of immunomodulation in allergic patients]

Allergol Immunopathol (Madr). 2000 May-Jun;28(3):102-7.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Allergens / administration & dosage
  • Allergens / therapeutic use
  • Animals
  • Anti-Allergic Agents / pharmacology
  • Anti-Allergic Agents / therapeutic use*
  • Antigens, Differentiation / pharmacology
  • Antigens, Differentiation / therapeutic use
  • Cell Adhesion Molecules / physiology
  • Chemokines / antagonists & inhibitors*
  • Chymases
  • Cytokines / antagonists & inhibitors*
  • Desensitization, Immunologic
  • Galectin 3
  • Humans
  • Hypersensitivity / immunology*
  • Immunoglobulin E / immunology
  • Interleukin-4 / antagonists & inhibitors
  • Interleukin-5 / antagonists & inhibitors
  • Mice
  • Peptide Fragments / administration & dosage
  • Peptide Fragments / therapeutic use
  • Serine Endopeptidases / immunology
  • Serine Proteinase Inhibitors / pharmacology
  • Serine Proteinase Inhibitors / therapeutic use
  • Tryptases
  • Vaccination

Substances

  • Adjuvants, Immunologic
  • Allergens
  • Anti-Allergic Agents
  • Antigens, Differentiation
  • Cell Adhesion Molecules
  • Chemokines
  • Cytokines
  • Galectin 3
  • Interleukin-5
  • Peptide Fragments
  • Serine Proteinase Inhibitors
  • Tpsb2 protein, mouse
  • Interleukin-4
  • Immunoglobulin E
  • Serine Endopeptidases
  • chymase 2
  • Chymases
  • Tpsab1 protein, mouse
  • Tryptases